Earl Brown |
|
PhD McMaster University 1981
|
Questions and Answers (9) View all
-
Answer added in Molecular Biological Techniques17 How do I optimise PEG precipitation?By Hadrien Peyret · John Innes CentreEarl Brown · University of OttawaMy simple procedure for PEG preoccupation of virus supernatants such as influenza in allantoic fluid or VSV culture supernatant is to dissolve 8 % PEG... [more]My simple procedure for PEG preoccupation of virus supernatants such as influenza in allantoic fluid or VSV culture supernatant is to dissolve 8 % PEG8000 (W/V) directly into the sample (previously clarified by 4 k rpm X 15 min) by shaking and then incubate at 4 C for 1 hr. Pellet at 7 k rpm for 20 min in a Sorval GSA type preparative rotor. Drain and resuspend in PBS or STE and do further purification for virus ore extract nucleic acid directly from the concentrate.Following
-
Answer added in Protein Quantification10 Using Urea for protein solubilization and iTRAQ labelingBy Daniel Garcia de la serrana · University of St AndrewsEarl Brown · University of OttawaWhen I was doing 2-dimentional thin layer tryptic mapping back in the dark ages, the solution to dissolving acetone and TCA protein pellets was to dis... [more]When I was doing 2-dimentional thin layer tryptic mapping back in the dark ages, the solution to dissolving acetone and TCA protein pellets was to dissolve in 70 % formic acid followed by dilution with 4 vol water and lyophilization. The fluffy protein was then soluble in bicarbonate buffer and very susceptible to complete tryptic digestion with removal of bicarbonate by lyophilization again. I used to do my chemical modificaions of oxidation of methionines and carboxymethylation of cysteine upstream of this step so that I had salt free tryptic peptides for thin layer electrophoresis and chromatography that are sensitive to salt overloading.Following
-
Answer added in IgG5 Can human derived intravenous immunoglobulin be used in experimental models of rats or mice?By Zhuolun Song · Tianjin Medical UniversityEarl Brown · University of OttawaYou can use human IgG to treat viral infections in mice as I have for influenza models in mice; see recent publication: http://www.frontiersin.org/B_C... [more]You can use human IgG to treat viral infections in mice as I have for influenza models in mice; see recent publication: http://www.frontiersin.org/B_Cell_Biology/10.3389/fimmu.2012.00087/abstract . Cross species passive transfers such as this will stimulate cross-reactive immunity and will give "serum-sickness" if used repeatedly with time to seroconvert between treatments (ie 1-2 weeks).Following
-
Answer added in Cancer Biology5 Which mouse models have been proven to resemble gene expression patterns and the histology of human disease?By Yoganathan Ramia Krishnamoorthy · Hadassah Medical CenterEarl Brown · University of OttawaThe mouse model of pneumonia due to infection with mouse-adapted influenza strains (and some natural isolates) has the same gross and histopathology ... [more]The mouse model of pneumonia due to infection with mouse-adapted influenza strains (and some natural isolates) has the same gross and histopathology as infection of human lungs with human influenza strains. Some gene expression patterns are similar ie IFN and other cytokines however gene expression similarities between human and mouse influenza infection is the subject of current research.Following
-
Answer added in Mouse Models9 What is the minimum number of mice that can be used for LD50 assay?By Ikhtifar Rafi · Ministry of Health MalaysiaEarl Brown · University of OttawaThe Reed and Muench interpolates the ld50 between the 2 dosages that bracket the 50% point and thus involves the researcher inserting themselves into ... [more]The Reed and Muench interpolates the ld50 between the 2 dosages that bracket the 50% point and thus involves the researcher inserting themselves into the calculation which moreover one degree of freedom and reduces the statistical strength of the assay. The karber-spearmen uses all the data and calculates the LD50 from all cumulative mortality. The following 2 manuscripts compare the karber method to others http://www.ncbi.nlm.nih.gov/pubmed/15190695 http://www.ncbi.nlm.nih.gov/pubmed/11800465Following
Publications (79) View all
-
Article: Low-pathogenic avian influenza virus A/turkey/Ontario/6213/1966 (H5N1) is the progenitor of highly pathogenic A/turkey/Ontario/7732/1966 (H5N9).
[show abstract] [hide abstract]
ABSTRACT: The first confirmed outbreak of highly pathogenic avian influenza (HPAI) virus infections in North America was caused by A/turkey/Ontario/7732/1966 (H5N9); however, the phylogeny of this virus is largely unknown. This study performed genomic sequence analysis of 11 avian influenza isolates from 1956 to 1979 for comparison with A/turkey/Ontario/7732/1966 (H5N9). Phylogenetic and genetic analyses included these viruses in combination with all known full-genome sequences of avian viruses isolated before 1981. It was shown that a low-pathogenic avian influenza virus, A/turkey/Ontario/6213/1966 (H5N1), that had been isolated 3 months previously, was the closest known genetic relative with six genome segments of common lineage encoding the polymerase subunits PB2, PB1 and PA, nucleoprotein (NP), haemagglutinin (HA) and non-structural (NS) proteins. The lineages of these genome segments included reassortment with other North American turkey viruses that were all rooted in North American wild waterfowl with the HA gene originating from the H5N2 serotype. The phylogenies demonstrated adaptation from North American wild birds to turkeys with the possible involvement of domestic waterfowl. The turkey isolate, A/turkey/Wisconsin/1968 (H5N9), was the second most closely related poultry isolate to A/turkey/Ontario/7732/1966 (H5N9), possessing five common lineage genome segments (PB2, PB1, PA, HA and neuraminidase). The A/turkey/Ontario/6213/1966 (H5N1) virus was more virulent than A/turkey/Wisconsin/68 (H5N9) for chicken embryos and mice, indicating a greater biological similarity to A/turkey/Ontario/7732/1966 (H5N9). Thus, A/turkey/Ontario/6213/1966 (H5N1) was identified as the closest known ancestral relative of HPAI A/turkey/Ontario/7732/1966 (H5N9), which will serve as a useful reference virus for characterizing the early genetic and biological properties associated with the emergence of pathogenic avian influenza strains.Journal of General Virology 05/2012; 93(Pt 8):1649-57. · 3.36 Impact Factor -
Article: Genetic analysis of H3 subtype influenza viruses isolated from domestic ducks in northern China during 2004-2005.
[show abstract] [hide abstract]
ABSTRACT: The broad distribution and prevalence of H3 subtype influenza viruses in avian and mammalian hosts constitutes a global threat to both human and veterinary health. In this present study, six H3N8 influenza viruses isolated from domestic ducks during 2004-2005 in northern China were genetically and phylogenetically characterized. Sequence analysis showed that HA, NA, and M genes of all the six H3N8 isolates had a close relationship with those of Equine/Jilin/1/89 (H3N8) virus, which once caused outbreak in equine populations in northern China. The PB2 and PA genes of the viruses possessed the highest similarities with highly pathogenic avian H5N1 influenza viruses currently circulating in this region. These findings emphasize the importance of avian influenza virus surveillance in this region for understanding the genesis and emergency of novel reassortants with pandemic potential.Virus Genes 01/2009; 38(1):136-42. · 1.85 Impact Factor -
Chapter: Additive Inhibition of H1N1 and H3N2 Influenza Viruses by Aurintricarboxylic Acid With Amantadine
Anathea S Flaman, Homan Albaghdadi, Jeff McClintock, Todd Cutts, Anwar M Hashem, Matt LeBrun, John Austin, Earl Brown, Runtao He, Xuguang Li01/2008: pages 478-479; , ISBN: 978-1-901-769-15-6 -
SourceAvailable from: Earl Brown
Article: Pandemic H1N1 Influenza Infection and Vaccination in Humans Induces Cross-Protective Antibodies that Target the Hemagglutinin Stem.
C A Thomson, Y Wang, L M Jackson, M Olson, W Wang, A Liavonchanka, L Keleta, V Silva, S Diederich, R B Jones, J Gubbay, J Pasick, M Petric, François Jean, V G Allen, E G Brown, J M Rini, J W Schrader[show abstract] [hide abstract]
ABSTRACT: Most monoclonal antibodies (mAbs) generated from humans infected or vaccinated with the 2009 pandemic H1N1 (pdmH1N1) influenza virus targeted the hemagglutinin (HA) stem. These anti-HA stem mAbs mostly used IGHV1-69 and bound readily to epitopes on the conventional seasonal influenza and pdmH1N1 vaccines. The anti-HA stem mAbs neutralized pdmH1N1, seasonal influenza H1N1 and avian H5N1 influenza viruses by inhibiting HA-mediated fusion of membranes and protected against and treated heterologous lethal infections in mice with H5N1 influenza virus. This demonstrated that therapeutic mAbs could be generated a few months after the new virus emerged. Human immunization with the pdmH1N1 vaccine induced circulating antibodies that when passively transferred, protected mice from lethal, heterologous H5N1 influenza infections. We observed that the dominant heterosubtypic antibody response against the HA stem correlated with the relative absence of memory B cells against the HA head of pdmH1N1, thus enabling the rare heterosubtypic memory B cells induced by seasonal influenza and specific for conserved sites on the HA stem to compete for T-cell help. These results support the notion that broadly protective antibodies against influenza would be induced by successive vaccination with conventional influenza vaccines based on subtypes of HA in viruses not circulating in humans.Frontiers in immunology. 01/2012; 3:87. -
Article: Critical negative regulation of type 1 T cell immunity and immunopathology by signaling adaptor DAP12 during intracellular infection.
Maziar Divangahi, Tony Yang, Kapilan Kugathasan, Sarah McCormick, Shunsuke Takenaka, Gordon Gaschler, Ali Ashkar, Martin Stampfli, Jack Gauldie, Jonathan Bramson, Toshiyuki Takai, Earl Brown, Wayne M Yokoyama, Naoko Aoki, Zhou Xing[show abstract] [hide abstract]
ABSTRACT: Transmembrane signaling adaptor DAP12 has increasingly been recognized for its important role in innate responses. However, its role in the regulation of antimicrobial T cell responses has remained unknown. In our current study, we have examined host defense, T cell responses, and tissue immunopathology in models of intracellular infection established in wild-type and DAP12-deficient mice. During mycobacterial infection, lack of DAP12 leads to pronounced proinflammatory and Th1 cytokine responses, overactivation of Ag-specific CD4 and CD8 T cells of type 1 phenotype, and heightened immunopathology both in the lung and lymphoid organs. DAP12-deficient airway APC display enhanced NF-kappaB activation and cytokine responses upon TLR stimulation or mycobacterial infection in vitro. Of importance, adoptive transfer of Ag-loaded DAP12-deficient APC alone could lead to overactivation of transferred transgenic or endogenous wild-type T cells in vivo. We have further found that the immune regulatory role by DAP12 is not restricted only to intracellular bacterial infection, since lack of this molecule also leads to uncontrolled type 1 T cell activation and severe immunopathology and tissue injury during intracellular viral infection. Our study thus identifies DAP12 as an important novel immune regulatory molecule that acts, via APC, to control the level of antimicrobial type 1 T cell activation and immunopathology.The Journal of Immunology 10/2007; 179(6):4015-26. · 5.79 Impact Factor